Umbilical cord blood is an extremely valuable biological material that savesnlives. The value of the umbilical cord blood is in the large number ofnhematopoietic stem cells that it contains. According to cell composition,numbilical cord blood is similar to bone marrow, so it can be used in thentreatment of diseases in which its transplantation is indicated. And these arenleukemias and lymphomas, congenital metabolic diseases, genetically mediated immunodeficiencies, thalassemias, autoimmune diseases, and many others.
Since 1988, more than 40,000 cord blood transplants have been performed in the world, and the storage of this biological material in developed countries is funded by the state. Nevertheless, not all future parents and even healthcare workers know about the value of umbilical cord blood and the possibility of its storage.
In order to disseminate knowledge about the value of umbilical cord blood that can save lives, the July month in the United States is approved as a umbilical cord blood awareness month. This means that during July, public organizations and doctors’ societies are carrying out numerous promotions and educational campaigns to raise awareness on the medical significance of
umbilical cord blood, giving lectures for future parents and health professionals, and broadcasting films and programs, covering successful cases of treatment with cord blood stem cells.
In Ukraine, the Institute of Cell Therapy, with the support of the Association of Cryobanks, was the first to catch up with the initiative of American colleagues to acknowledge July as a month of cord blood awareness. During July, our leading experts will be giving lectures on issues of storage and clinical use of umbilical cord blood and other educational activities.
Since 2003, the first Cryobank of Ukraine has been providing future parents the opportunity to present their child a health reserve for many years, having saved the umbilical cord blood, placenta and umbilical cord stem cells, collected at birth.